Global Custom Market Research Reports Provider Company

phone

Mayne Pharma Group Ltd (MYX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: Australia
Summary

Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd is a healthcare company that develops, manufactures, and commercializes branded and generic medicinal products. The companys products include astrix capsules and tablets, erymax capsules, kapanol capsules, doryx capsules, magnoplasm, and lozanoc and itragerm capsules. It offers services such as product development, analytical development, contract manufacturing, formulation development, logistics, packing services, pre-clinical and clinical development, process development and validation services. Mayne Pharma provides products in the dosage forms of powder, liquid, tablets, capsules, and cream. The company operates through manufacturing facilities located in Salisbury, Australia and Greenville, the US. Mayne Pharma is headquartered in Salisbury South, Victoria, Australia.

Mayne Pharma Group Ltd Key Recent Developments

Aug 08,2017: Mayne Pharma Market Update
Mar 09,2017: Mayne Pharma appoints new Group CFO and Company Secretary
Jan 16,2017: Mayne Pharma Announces Leadership Changes
Sep 21,2016: Mayne Pharma Appoints New Director
Jul 29,2016: Mayne Pharma Announces Settlement From Patent Infringement Case

This comprehensive SWOT profile of Mayne Pharma Group Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mayne Pharma Group Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Mayne Pharma Group Ltd - Key Information

Mayne Pharma Group Ltd - Overview

Mayne Pharma Group Ltd - Key Employees

Mayne Pharma Group Ltd - Key Employee Biographies

Mayne Pharma Group Ltd - Key Operational Heads

Mayne Pharma Group Ltd - Major Products and Services

Mayne Pharma Group Ltd - History

Mayne Pharma Group Ltd - Company Statement

Mayne Pharma Group Ltd - Locations And Subsidiaries

Mayne Pharma Group Ltd - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Mayne Pharma Group Ltd - Business Description

Mayne Pharma Group Ltd - Corporate Strategy

Mayne Pharma Group Ltd - SWOT Analysis

SWOT Analysis - Overview

Mayne Pharma Group Ltd - Strengths

Mayne Pharma Group Ltd - Weaknesses

Mayne Pharma Group Ltd - Opportunities

Mayne Pharma Group Ltd - Threats

Mayne Pharma Group Ltd - Key Competitors



Section 3 - Company Financial Performance Charts



Mayne Pharma Group Ltd - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Mayne Pharma Group Ltd, Key Information

Mayne Pharma Group Ltd, Key Ratios

Mayne Pharma Group Ltd, Share Data

Mayne Pharma Group Ltd, Major Products and Services

Mayne Pharma Group Ltd, History

Mayne Pharma Group Ltd, Key Employees

Mayne Pharma Group Ltd, Key Employee Biographies

Mayne Pharma Group Ltd, Key Operational Heads

Mayne Pharma Group Ltd, Other Locations

Mayne Pharma Group Ltd, Subsidiaries

Mayne Pharma Group Ltd, Key Manufacturing facilities

Mayne Pharma Group Ltd, Key Competitors

Mayne Pharma Group Ltd, SWOT Analysis

Mayne Pharma Group Ltd, Ratios based on current share price

Mayne Pharma Group Ltd, Annual Ratios

Mayne Pharma Group Ltd, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Mayne Pharma Group Ltd, Performance Chart

Mayne Pharma Group Ltd, Ratio Charts

Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd is a healthcare company that develops, manufactures, and commercializes branded and generic medicinal products. The companys products include

View Report

Mayne Pharma Group Limited (MYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report

Mayne Pharma Limited - Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports